Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...
People living with myasthenia gravis (MG) and their families have average out-of-pocket expenses of more than $15,000 per year, according to a recent Economic Burden of Myasthenia Gravis survey.
Suzuki Motors plans to supply the all-new battery electric vehicle SUV model to Toyota Motor Corporation from the early months of 2025. The company is set to begin manufacturing in spring 2025 at ...